S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
S&P 500   3,116.39 (-0.38%)
DOW   26,957.59 (-0.46%)
QQQ   216.48 (+0.52%)
AAPL   292.65 (+1.59%)
FB   197.20 (+0.22%)
MSFT   170.17 (+1.25%)
GOOGL   1,390.47 (+0.30%)
AMZN   1,979.59 (+0.35%)
CGC   19.82 (+1.02%)
NVDA   267.65 (+2.14%)
BABA   208.74 (+1.52%)
MU   52.37 (+0.52%)
GE   10.95 (-3.27%)
TSLA   778.80 (-2.64%)
AMD   47.49 (-0.17%)
T   37.10 (-0.67%)
ACB   1.51 (+0.00%)
F   7.21 (-0.28%)
NFLX   379.24 (+5.32%)
PRI   120.14 (-1.05%)
BAC   30.63 (-1.45%)
DIS   123.36 (-3.77%)
GILD   74.70 (+6.56%)
Log in

NASDAQ:VRML - Vermillion Stock Price, Forecast & News

$0.89
-0.05 (-5.32 %)
(As of 02/26/2020 04:00 PM ET)
Today's Range
$0.85
Now: $0.89
$0.95
50-Day Range
$0.75
MA: $0.82
$0.95
52-Week Range
$0.35
Now: $0.89
$1.57
Volume83,800 shs
Average Volume106,326 shs
Market Capitalization$86.54 million
P/E RatioN/A
Dividend YieldN/A
Beta3.46
Vermillion, Inc, together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VRML
CUSIPN/A
Phone512-519-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.05 million
Book Value$0.09 per share

Profitability

Net Income$-11,370,000.00
Net Margins-353.32%

Miscellaneous

Employees43
Market Cap$86.54 million
Next Earnings Date3/26/2020 (Estimated)
OptionableOptionable

Receive VRML News and Ratings via Email

Sign-up to receive the latest news and ratings for VRML and its competitors with MarketBeat's FREE daily newsletter.


Vermillion (NASDAQ:VRML) Frequently Asked Questions

What is Vermillion's stock symbol?

Vermillion trades on the NASDAQ under the ticker symbol "VRML."

How were Vermillion's earnings last quarter?

Vermillion, Inc. (NASDAQ:VRML) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.06) EPS for the quarter. The company earned $1.14 million during the quarter. Vermillion had a negative return on equity of 163.08% and a negative net margin of 353.32%. View Vermillion's Earnings History.

When is Vermillion's next earnings date?

Vermillion is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for Vermillion.

Has Vermillion been receiving favorable news coverage?

News stories about VRML stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Vermillion earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Vermillion.

Are investors shorting Vermillion?

Vermillion saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,420,000 shares, an increase of 24.8% from the December 31st total of 2,740,000 shares. Based on an average daily volume of 218,800 shares, the days-to-cover ratio is presently 15.6 days. Approximately 6.7% of the shares of the company are short sold. View Vermillion's Current Options Chain.

Who are some of Vermillion's key competitors?

What other stocks do shareholders of Vermillion own?

Who are Vermillion's key executives?

Vermillion's management team includes the folowing people:
  • Ms. Valerie Barber Palmieri, CEO, Pres & Director (Age 58)
  • Mr. Robert Harry Beechey CPA, Chief Financial Officer (Age 56)
  • Mr. Chris Goulart, Sr. VP of Commercial Operations

Who are Vermillion's major shareholders?

Vermillion's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include B. Riley Wealth Management Inc. (0.46%), Alyeska Investment Group L.P. (0.29%), Geode Capital Management LLC (0.25%), Cannell Peter B & Co. Inc. (0.12%), Magnus Financial Group LLC (0.09%) and Trellus Management Company LLC (0.05%). Company insiders that own Vermillion stock include David Schreiber, Jack W Schuler, James T Lafrance, Robert Harry Beechey and Valerie Barber Palmieri. View Institutional Ownership Trends for Vermillion.

Which institutional investors are selling Vermillion stock?

VRML stock was sold by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P. and Cannell Peter B & Co. Inc.. View Insider Buying and Selling for Vermillion.

Which institutional investors are buying Vermillion stock?

VRML stock was acquired by a variety of institutional investors in the last quarter, including B. Riley Wealth Management Inc., Trellus Management Company LLC, Geode Capital Management LLC and Magnus Financial Group LLC. Company insiders that have bought Vermillion stock in the last two years include Jack W Schuler, Robert Harry Beechey and Valerie Barber Palmieri. View Insider Buying and Selling for Vermillion.

How do I buy shares of Vermillion?

Shares of VRML can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Vermillion's stock price today?

One share of VRML stock can currently be purchased for approximately $0.89.

How big of a company is Vermillion?

Vermillion has a market capitalization of $86.54 million and generates $3.05 million in revenue each year. Vermillion employs 43 workers across the globe.View Additional Information About Vermillion.

What is Vermillion's official website?

The official website for Vermillion is http://www.vermillion.com/.

How can I contact Vermillion?

Vermillion's mailing address is 12117 BEE CAVES ROAD BUILDING THREE SUITE 100, AUSTIN TX, 78738. The company can be reached via phone at 512-519-0400 or via email at [email protected]


MarketBeat Community Rating for Vermillion (NASDAQ VRML)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  199 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  397
MarketBeat's community ratings are surveys of what our community members think about Vermillion and other stocks. Vote "Outperform" if you believe VRML will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRML will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel